Immunotherapy Results for Mesothelioma
Information on survival rates and results of patients with malignant mesothelioma, pleural mesothelioma, and peritoneal mesothelioma who included immunotherapy in their treatment plans.
Survival | Patients | Toxicity | Treatment | Hospital | Country | Date |
---|---|---|---|---|---|---|
29.2 months | Malignant Pleural Mesothelioma | 3 | Chemotherapy Immunotherapy | Center Hospitalier Intercommunal de Creteil | France | 6/2002 |
26.8 months | Pleural mesothelioma | 5 | Chemotherapy | H. Lee Moffitt Cancer Center and Research Institute | United States | 7/2008 |
26.0 months | Mesothelioma | 3 | Chemotherapy Immunotherapy Radiation Surgery | University of Pisa | Italy | 12/2006 |
23.0 months | MPM | 5 | Chemotherapy Surgery | University Hospital Zurich | Switzerland | 4/2007 |
23.0 months | Malignant pleural mesothelioma | 3 | Biologic therapy Surgery | New York University School of Medicine | United States | 8/2008 |
18.1 months | Malignant Pleural Mesothelioma | 5 | Radiation < Surgery | University of California, San Francisco | United States | 12/2002 |
18.0 months | Malignant Pleural Mesothelioma | 3 | Immunotherapy | Hopital de la Conception | France | 11/1998 |
17.8 months | Malignant Pleural Mesothelioma | 5 | Biologic therapy < Chemotherapy | Medical University of Lubeck | Germany | 3/2003 |
16.8 months | Malignant pleural mesothelioma | 4 | Chemotherapy Radiation Surgery | Memorial Sloan-Kettering Cancer Center | United States | 6/2009 |
15.0 months | Malignant Pleural Mesothelioma | 3 | Immunotherapy | Ospedale S. Spirito | Italy | 2/2001 |
14.8 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | Newcastle General Hospital | United Kingdom | 8/2002 |
14.0 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | Ospedale ‘Villa Scassi’ | Italy | 12/2007 |
14.0 months | Malignant pleural mesothelioma | 5 | Surgery | Memorial Sloan-Kettering Cancer Center | United States | 3/2008 |
13.1 months | Malignant pleural mesothelioma | 5 | Chemotherapy Surgery | Brigham and Women’s Hospital | United States | 8/2009 |
13.0 months | Malignant Pleural Mesothelioma | 4 | Alternative Chemotherapy | University of Turin | Italy | 4/2003 |
13.0 months | Mesothelioma | 5 | Chemotherapy Surgery | Brigham and Women’s Hospital | United States | 4/2006 |
12.7 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | Istituto Clinico Humanitas | Italy | 3/2006 |
12.7 months | MPM | 4 | Chemotherapy Immunotherapy | C. Forlanini Hospital | Italy | 1/2005 |
12.4 months | Malignant pleural mesothelioma | Surgery | Medical University of Vienna | Austria | 4/2008 | |
12.1 months | Malignant Pleural Mesothelioma | 5 | Alternative Chemotherapy | University of Chicago, Cancer Research Center | United States | 7/2003 |
12.0 months | Malignant Pleural Mesothelioma | 3 | Radiation Surgery | The University of Texas M. D. Anderson Cancer Center | United States | 3/2003 |
11.2 months | MPM | 5 | Chemotherapy | Emory University School of Medicine | United States | 5/2005 |
11.2 months | Malignant pleural mesothelioma | 4 | Chemotherapy | Sir Charles Gairdner Hospital | Australia | 8/2002 |
10.6 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | St Bartholomew’s Hospital | United Kingdom | 12/2000 |
10.5 months | Malignant Mesothelioma | 3 | Biologic therapy < Chemotherapy | The Royal Marsden Hospital | United Kingdom | 2/2002 |
10.3 months | Malignant peritoneal mesothelioma | 5 | Chemotherapy | Cardarelli Hospital | Italy | 5/2009 |
10.1 months | Malignant pleural mesothelioma | 4 | Chemotherapy | Institut Gustave Roussy | France | 1/2003 |
10.1 months | Malignant pleural mesothelioma | 4 | Chemotherapy | Dana Farber Cancer Institute | United States | 3/2008 |
10.0 months | Malignant Mesothelioma | 4 | Chemotherapy | National University Hospital, Rigshospitalet | Denmark | 4/1999 |
10.0 months | Malignant pleural mesothelioma | 4 | Radiation Surgery | Memorial Sloan-Kettering Cancer Center | United States | 10/2001 |
10.0 months | Malignant Pleural Mesothelioma | 5 | Biologic therapy Surgery | The Netherlands Cancer Institute | Netherlands | 10/2001 |
9.7 months | Advanced malignant pleural mesothelioma | 4 | Chemotherapy | Medical University of Gdansk | Poland | 4/2008 |
9.6 months | Malignant Mesothelioma | 5 | Chemotherapy | University of Chicago Medical Center | United States | 11/1999 |
9.6 months | Malignant pleural mesothelioma | 4 | Chemotherapy | Charing Cross Hospital | United Kingdom | 5/2008 |
9.5 months | Malignant pleural mesothelioma | 5 | Chemotherapy | Leeds General Infirmary | United Kingdom | 5/2008 |
9.4 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | University Hospital Rotterdam | Netherlands | 2/2002 |
9.3 months | MPM | 5 | Chemotherapy | University of Chicago | United States | 6/2005 |
9.3 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy Immunotherapy | Istituto Clinico Humanitas | Italy | 8/2001 |
9.3 months | Malignant Pleural Mesothelioma | 4 | Alternative Chemotherapy | University of Chicago, Cancer Research Center | United States | 7/2003 |
9.0 months | Malignant Pleural Mesothelioma | 2 | Immunotherapy | St. Bartholomew’s Hospital | United Kingdom | 1/2001 |
8.8 months | MPM | 4 | Chemotherapy | St. Bartholomew’s Hospital | United Kingdom | 2/2005 |
8.8 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | University Hospital Vrije Universiteit | Netherlands | 11/1997 |
8.7 months | Malignant Pleural Mesothelioma | 1 | Radiation | Sir Charles Gairdner Hospital | Australia | 7/2004 |
8.5 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | The University of Texas M.D. Anderson Cancer Center | United States | 8/2000 |
8.2 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | Erasmus Medical Center | Netherlands | 4/2002 |
8.0 months | Malignant Pleural Mesothelioma | 4 | Chemotherapy | University of Turin | Italy | 4/2003 |
7.6 months | MPM | 3 | Biologic therapy | Netherlands Cancer Institute | Netherlands | 5/2005 |
7.0 months | Malignant pleural mesothelioma | 3 | Chemotherapy | The Netherlands Cancer Institute | Netherlands | 2/2003 |
7.0 months | Malignant Mesothelioma | 5 | Chemotherapy | Columbia University | United States | 7/2003 |
6.8 months | Advanced mesothelioma | 5 | Chemotherapy | Washington University School of Medicine | United States | 3/2005 |
6.6 months | Malignant Mesothelioma | 4 | Chemotherapy | University of Chicago Medical Center | United States | 11/1999 |
6.0 months | Unresectable Malignant Mesothelioma | 4 | Chemotherapy | Alfacell Corp. | United States | 1/2002 |
5.8 months | Malignant pleural mesothelioma | 4 | Biologic therapy | Dana-Farber Cancer Institute | United States | 6/2008 |
4.9 months | Malignant Mesothelioma | 5 | Chemotherapy | Ohio State University Comprehensive Cancer Center | United States | 5/2004 |
4.8 months | Malignant Mesothelioma | 5 | Chemotherapy | Scripps Clinic | United States | 11/2001 |
4.7 months | Malignant Mesothelioma | 5 | Chemotherapy | University of Chicago Medical Center | United States | 2/2001 |
3.2 months | MPM | 3 | Chemotherapy | San Matteo University Hospital | Italy | 6/2005 |
N/R | Mesothelioma | 3 | Alternative | University of Texas, M. D. Anderson Cancer Center | United States | 3/2001 |
N/R | MPM | 4 | Biologic therapy | Erasmus Medical Center | Netherlands | 2/2005 |
More | Mesothelioma | 4 | Immunotherapy | Memorial Hermann Hospital | United States | 12/2002 |
More | Mesothelioma | 4 | Biologic therapy | Massachusetts General Hospital | United States | 2/2001 |
More | Malignant Pleural Mesothelioma | 4 | Chemotherapy | IST Istituto Nazionale per la Ricerca sul Cancro | Italy | 11/2001 |
More | Mesothelioma | 4 | Chemotherapy | University of Minnesota Medical School | United States | 1/2002 |